Skip to main content

Table 4 Three-year CRC survival as a function of different factors (univariate and multivariate analysis)

From: Impact of the faecal immunochemical test on colorectal cancer survival

 

UNIVARIATE ANALYSIS

MULTIVARIATE ANALYSIS

% Three-year CRC survival

Standard error

P

HR

95% CI

GROUPSa

 Group 1

72

0.03

< 0.0005

1

 

 Group 2

59

0.01

 

1.50

1.22–1.84

AGE (years)

  ≤ 49

80

0.05

 

1

 

 50–69

72

0.02

 

1.35

0.83–2.19

  ≥ 70

54

0.02

< 0.0005

2.96

1.85–4.75

SITES

 Rectum

57

0.03

   

 Distal colon

62

0.02

< 0.25

  

 Proximal colon

63

0.02

   

HISTOLOGY

 Adenocarcinoma

61

0.01

 

1

 

 Mucinous adenocarcinoma

73

0.06

0.18

0.53

0.34–0.83

 Othersb

42

0.09

 

1.32

0.81–2.14

STAGE

 Stage I

92

0.02

 

1

 

 Stage II

82

0.02

< 0.0005

1.32

0.97–1.79

 Stage III

67

0.03

 

2.18

1.61–2.95

 Stage IV

18

0.02

 

8.83

6.63–11.77

  1. HR hazard ratio, CI confidence interval aGroup 1; with positive faecal immunochemical test results in the previous 12 months. Group 2: patients that either did not performed any FIT in the previous 12 months before diagnosis or display a negative FIT bOther: signet ring cell carcinoma, neuroendocrine carcinoma, squamous cell carcinoma
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us